An Australian stem cell and regenerative medicine company

ASX Announcements

16 Jun 2020 Appendix 3Y-Stewart Washer
16 Jun 2020 Dr Darryl Maher joins Cynata Board
16 Jun 2020 Block Trade Proceeds to Reduce Director Loans
10 Jun 2020 Appendix 2A
10 Jun 2020 Investor Presentation
02 Jun 2020 Appendix 2A
27 May 2020 Cynata Successfully Completes Share Purchase Plan
08 May 2020 Ethics Approval to Commence Clinical Trial in COVID-19
01 May 2020 Cleansing Notice
01 May 2020 Appendix 2A
30 Apr 2020 Share Purchase Plan Booklet
24 Apr 2020 Cleansing Notice
24 Apr 2020 Appendix 2A
24 Apr 2020 Quarterly Activity Report & Appendix 4C
22 Apr 2020 Cynata Announces $5.55m capital raising
22 Apr 2020 Proposed Issue of Securities
20 Apr 2020 Trading Halt
17 Apr 2020 Cynata MSCs beneficial in preclinical ARDS study
01 Apr 2020 Cynata provides guidance on planned clinical trials
11 Mar 2020 Market Update & Additional A$618k R&D Tax Refund
10 Mar 2020 Cynata Receives Japan Patent Notice of Allowance
03 Mar 2020 Canadian Patent Issued for CYP Unique Stem Cell Technology
20 Feb 2020 Appendix 4D & Half-Year Financial Statements
06 Feb 2020 Notice of Allowance from Israel Patent Office
31 Jan 2020 Cynata Investor Presentation
30 Jan 2020 December 2019 Quarterly Report
14 Jan 2020 Cynata Receives UK Regulatory Approval for CLI Trial
07 Jan 2020 Cynata Receives $1.892m R&D Tax Incentive Refund
16 Dec 2019 Appendix 3Y-Dr Paul Wotton
09 Dec 2019 Corporate Presentation in Relation to Sepsis
05 Dec 2019 Cymerus MSCs Effective in Preclinical Model of Sepsis
27 Nov 2019 Results of Annual General Meeting
27 Nov 2019 Cynata Annual General Meeting Presentation
27 Nov 2019 Chairman's 2019 AGM Address
25 Nov 2019 CYP Files Application to Commence Phase 2 CLI Clinical Trial
18 Nov 2019 Appendix 3Y-Dr Paul Wotton
18 Nov 2019 Notification of Expiry of Unlisted Options
12 Nov 2019 Appendix 3Y-Mr Peter Webse
12 Nov 2019 Appendix 3Y-Dr Ross Macdonald
12 Nov 2019 Appendix 3Y-Dr Paul Wotton
12 Nov 2019 Cleansing Notice
12 Nov 2019 Appendix 3B-Exercise of Options
30 Oct 2019 Cynata Corporate Presentation
28 Oct 2019 Cynata Awarded Grant for Coronary Artery Disease Study
25 Oct 2019 Notice of Allowance from CIPO for Patent Application
24 Oct 2019 Annual Report to shareholders
24 Oct 2019 Notice of Annual General Meeting/Proxy Form
24 Oct 2019 September 2019 Quarterly Report
17 Oct 2019 Cynata & Sumitomo Withdraw from Acquisition Discussions
14 Oct 2019 Receipt of notice under section 249N of the Corporations Act